Skip to content
Open access · CC-BY via OpenAlex

INTERMITTENT FASTING AND LIPID METABOLISM: MECHANISMS, CLINICAL EVIDENCE, AND THERAPEUTIC IMPLICATIONS

Katarzyna Gołacka, Przemysław Szostak, Martyna Rynkowska, Sylwia Maj, Wiktoria Sikorska, Albert Sikorski, Dominika Kuźmiuk, Dominika Sidor, Rafał Gołacki, Joanna Marta Bystron

International Journal of Innovative Technologies in Social Science · 2026

Abstract

Intermittent fasting (IF) is a way of eating that can help the body burn fat more efficiently and lower the risk of heart disease. It leads to helpful changes in blood composition and in metabolism. Still, there are questions about how safe, practical, and effective IF is over the long term. Because of these unknowns, it is important to have clear guidelines for IF and to continue research in this area. Background & Aim: Common IF methods include alternate-day fasting (ADF), the 5:2 diet, time-restricted eating (TRE), and Ramadan fasting (RF). This review points out that we still do not fully understand how IF works in the body and highlights areas that need more study. The main aim is to show how dietary approaches can help manage metabolic diseases and support health, either on their own or alongside other treatments. Summary: IF consistently improves lipid profiles, insulin sensitivity, body weight, and indirectly, due to the above cardiometabolic risk factors in people with obesity, metabolic syndrome (MeS), and type 2 diabetes (T2D). However, its effects on high-density lipoprotein cholesterol (HDL-C) are mixed. When compared directly to continuous energy restriction (CER) with concomitant energy deficits, both approaches are similarly effective for improving lipid and weight outcomes. IF may provide additional benefits for short-term fat loss and adherence. Additionally, it may be a profitable alternative to or support of pharmacological therapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.31435/ijitss.3(51).2026.5918
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
Gołacka, K., Szostak, P., Rynkowska, M., Maj, S., Sikorska, W., Sikorski, A., Kuźmiuk, D., Sidor, D., Gołacki, R., &amp; Bystron, J.M. (2026). INTERMITTENT FASTING AND LIPID METABOLISM: MECHANISMS, CLINICAL EVIDENCE, AND THERAPEUTIC IMPLICATIONS. <em>International Journal of Innovative Technologies in Social Science</em>. https://doi.org/10.31435/ijitss.3(51).2026.5918
Vancouver
Gołacka K, Szostak P, Rynkowska M, Maj S, Sikorska W, Sikorski A, et al. INTERMITTENT FASTING AND LIPID METABOLISM: MECHANISMS, CLINICAL EVIDENCE, AND THERAPEUTIC IMPLICATIONS. International Journal of Innovative Technologies in Social Science. 2026. doi:10.31435/ijitss.3(51).2026.5918.
BibTeX
@article{katarzyna2026INTERM, title = {INTERMITTENT FASTING AND LIPID METABOLISM: MECHANISMS, CLINICAL EVIDENCE, AND THERAPEUTIC IMPLICATIONS}, author = {Katarzyna Gołacka and Przemysław Szostak and Martyna Rynkowska and Sylwia Maj and Wiktoria Sikorska and Albert Sikorski and Dominika Kuźmiuk and Dominika Sidor and Rafał Gołacki and Joanna Marta Bystron}, journal = {International Journal of Innovative Technologies in Social Science}, year = {2026}, doi = {10.31435/ijitss.3(51).2026.5918}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings